Floatz logo

Tapentadol

Osteoarthritis, Hip

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Small moleculePhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Osteoarthritis, Hip cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
Poznan University of Medical Sciences
Phase 4BBB
ROPIVACAINE
Poznan University of Medical Sciences
Phase 4BBB
DEXAMETHASONE
Poznan University of Medical Sciences
Phase 4BBB
Dfn-15
Pfizer
Phase 4BB
Intravenous Dexamethsone
Poznan University of Medical Sciences
Phase 4BB

View all 17 →

Same molecule, other indications

Tapentadol is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
osteoarthritisDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →